2019 American Transplant Congress
The Impact of Share 35 on Living Donor Liver Transplant Utilization in the United States: Analysis of UNOS Data
University of California, San Francisco, San Francisco, CA
*Purpose: In 2013, the Share 35 policy was implemented in the United States (US) to improve timely organ allocation to high MELD patients awaiting liver…2019 American Transplant Congress
Metabolic Liver Transplant: A Single Cooperative 2002-2017
*Purpose: Liver transplant (LT) can increase quality and quantity of life for patients with inherited metabolic diseases (IMDs) who suffer severe and unpredictable complications despite…2019 American Transplant Congress
Patient-Reported Self-Management in Lung Transplant Candidates
*Purpose: Pre-transplant risk factors are strongly associated with worse post-transplant survival (e.g. frailty); however, effective pre-transplant strategies to improve outcomes are lacking. We hypothesize that…2019 American Transplant Congress
Pre-Transplant Patient and Caregiver Assessments: A Systematic Review and Meta-Analysis
*Purpose: We sought to summarize the available literature regarding the psychosocial effects of the waiting period on pre-transplant adult heart or lung transplant candidates and…2019 American Transplant Congress
Ex Vivo Resection And Autologous Liver Transplantation As Management Concept For Extensive Malignancy
*Purpose: Neuroblastomas are rare neural crest derived tumors which contribute disproportionally to childhood morbidity and mortality. Surgical resection remains standard treatment, however adequate resection is…2019 American Transplant Congress
The Effect Of Missed Hemodialysis Treatment Prior To Transplant
*Purpose: Missed hemodialysis sessions confer heightened morbidity and mortality for ESRD patients. The effect of missed dialysis in the month prior to transplant on the…2019 American Transplant Congress
Evaluating Potentially Inappropriate Prescribing in Older Kidney Transplant Recipients
*Purpose: While the Beers criteria (BC) and STOPP criteria (SC) have been validated in several patient populations to reduce medication use leading to adverse drug…2019 American Transplant Congress
Is Pre-transplant Plasmapheresis For Patients With Insignificant Abo Blood Type Antibody In Abo Blood Type Incompatible Kidney Transplant Necessary? – A Japanese Single Center Study.
Urology and Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Hokkaido, Japan
*Purpose: ABO incompatible kidney donor (ABOiKT) is still precious to fill up the extremely organ donor shortages in our country. Though plasmaphresis (PP) as desensitization…2019 American Transplant Congress
Donor-Derived Cell-Free DNA (dd-cfDNA) Course after Rejection in Pediatric Kidney Transplant Recipients
*Purpose: Accurate identification of successful treatment for rejection (R) without repeat kidney biopsy (KB) in kidney transplantation is an unmet need. The few existing biomarkers…2019 American Transplant Congress
Donor Lymphocyte Chimerism and Homozygosity Are Critical Indicators for Timely and Accurate Diagnosis of Acute Graft vs. Host Disease after Liver Transplantation
Cleveland Clinic Foundation, Cleveland, OH
*Purpose: The mortality of Acute Graft vs. Host Disease (aGvHD) after Liver Transplantation (LT) can be greater than 85% due to delays in diagnosis and…
- « Previous Page
- 1
- …
- 174
- 175
- 176
- 177
- 178
- …
- 214
- Next Page »